Matches in SemOpenAlex for { <https://semopenalex.org/work/W86477267> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- W86477267 endingPage "92" @default.
- W86477267 startingPage "389" @default.
- W86477267 abstract "Ezetimibe (Sch-58235) is a cholesterol absorption inhibitor being developed by Schering-Plough for the potential treatment of atherosclerosis and hypercholesterolemia. By January 2000, it was in phase III trials in the US [353762], [363364]. Schering-Plough is studying ezetimibe as a monotherapy for lowering lipid levels and, by February 2000, it was also planning combination studies with commonly used statin (HMG-CoA reductase inhibitor) therapies. The company believes that ezetimibe will have additive effects with the statins, inhibiting the absorption of cholesterol in the intestine while the statins work by inhibiting the production of cholesterol in the liver [363364]. In May 2000, Merck signed an agreement with Schering-Plough to develop and market in the US a once-daily, fixed-combination tablet with simvastatin (Zocor) [368021]. This combination has been shown to improve LDL reduction to 52% as compared to 35% with Zocor alone [375966]." @default.
- W86477267 created "2016-06-24" @default.
- W86477267 creator A5067803190 @default.
- W86477267 date "2001-03-01" @default.
- W86477267 modified "2023-10-16" @default.
- W86477267 title "Ezetimibe (Schering-Plough)." @default.
- W86477267 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12054091" @default.
- W86477267 hasPublicationYear "2001" @default.
- W86477267 type Work @default.
- W86477267 sameAs 86477267 @default.
- W86477267 citedByCount "3" @default.
- W86477267 crossrefType "journal-article" @default.
- W86477267 hasAuthorship W86477267A5067803190 @default.
- W86477267 hasConcept C104950815 @default.
- W86477267 hasConcept C126322002 @default.
- W86477267 hasConcept C134651460 @default.
- W86477267 hasConcept C181199279 @default.
- W86477267 hasConcept C185592680 @default.
- W86477267 hasConcept C2776329913 @default.
- W86477267 hasConcept C2776839432 @default.
- W86477267 hasConcept C2778657065 @default.
- W86477267 hasConcept C55493867 @default.
- W86477267 hasConcept C71924100 @default.
- W86477267 hasConcept C98274493 @default.
- W86477267 hasConceptScore W86477267C104950815 @default.
- W86477267 hasConceptScore W86477267C126322002 @default.
- W86477267 hasConceptScore W86477267C134651460 @default.
- W86477267 hasConceptScore W86477267C181199279 @default.
- W86477267 hasConceptScore W86477267C185592680 @default.
- W86477267 hasConceptScore W86477267C2776329913 @default.
- W86477267 hasConceptScore W86477267C2776839432 @default.
- W86477267 hasConceptScore W86477267C2778657065 @default.
- W86477267 hasConceptScore W86477267C55493867 @default.
- W86477267 hasConceptScore W86477267C71924100 @default.
- W86477267 hasConceptScore W86477267C98274493 @default.
- W86477267 hasIssue "3" @default.
- W86477267 hasLocation W864772671 @default.
- W86477267 hasOpenAccess W86477267 @default.
- W86477267 hasPrimaryLocation W864772671 @default.
- W86477267 hasRelatedWork W132670735 @default.
- W86477267 hasRelatedWork W1952267466 @default.
- W86477267 hasRelatedWork W1969057629 @default.
- W86477267 hasRelatedWork W1977292444 @default.
- W86477267 hasRelatedWork W2008490947 @default.
- W86477267 hasRelatedWork W2029573792 @default.
- W86477267 hasRelatedWork W2035229581 @default.
- W86477267 hasRelatedWork W2370491317 @default.
- W86477267 hasRelatedWork W2413521381 @default.
- W86477267 hasRelatedWork W2498434420 @default.
- W86477267 hasVolume "2" @default.
- W86477267 isParatext "false" @default.
- W86477267 isRetracted "false" @default.
- W86477267 magId "86477267" @default.
- W86477267 workType "article" @default.